Omrix Biopharmaceuticals SA
1.0 FTEOmrix Biopharmaceuticals reported revenue of €107.0m for the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026), with 1 full-time equivalent.
By total assets for 2025, Omrix Biopharmaceuticals ranks among the 50 largest of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Omrix Biopharmaceuticals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +30 % Equity +8 % Total assets +75 % Headcount (avg FTE) -50 %
Accounts of the company itself (not consolidated).
The full file covers 12 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Omrix Biopharmaceuticals's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €107.0m | ||||
| Net result | 31,966 € | ||||
| Equity | €18.5m | ||||
| Cash | 106,978 € | ||||
| EBITDA | −€1.11m | ||||
| Total assets | €66.5m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 11 Jul 2025
- Year ended 31 Dec 2023filed on 05 Jul 2024
- Year ended 31 Dec 2022filed on 10 Jul 2023
- Year ended 31 Dec 2021filed on 27 Jun 2022
Omrix Biopharmaceuticals's financial analysis
- Solvency27.7%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Omrix Biopharmaceuticals
Omrix Biopharmaceuticals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0455.883.073
- VAT number
- BE0455883073
- Peppol
- Registered · 0208:0455883073 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 31 Aug 1995
- Registered office
- 1831 Machelen (Brab.)
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Omrix Biopharmaceuticals (SA) has been based in Machelen (Brab.) since 1995, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €107.0m, a net profit of 31,966 € and equity of €18.5m. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 27.7%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Omrix Biopharmaceuticals
Companies in the same business, of comparable size and area, outside its group.
- Gilead Sciences Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €68.7m
- sandoz Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €55.3m
- O&M Halyard Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €45.9m
- Takeda Belgium Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €86.4m
- Med Concept Europe Wholesale of pharmaceutical and medical goods Woluwe-Saint-Pierre · balance sheet €18.7m
- Chiesi Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €32.4m
- Elekta Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €13.1m
- Almirall Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €7.75m
Frequently asked questions about Omrix Biopharmaceuticals
What is the revenue of Omrix Biopharmaceuticals?
According to the 2025 annual accounts filed with the NBB, the revenue of Omrix Biopharmaceuticals amounts to 106,951,096 €.
What is the VAT number of Omrix Biopharmaceuticals?
In Belgium, the VAT number is the company number prefixed with BE: BE0455883073 for Omrix Biopharmaceuticals, if the company is VAT-registered. Its company number (CBE) is 0455.883.073.
Where is the registered office of Omrix Biopharmaceuticals?
According to the CBE register, the registered office of Omrix Biopharmaceuticals is in 1831 Machelen (Brab.).
What is the equity of Omrix Biopharmaceuticals?
At the close of the 2025 financial year, the equity of Omrix Biopharmaceuticals amounts to 18,450,412 €, a solvency of 27.7% of total assets.
How many people work at Omrix Biopharmaceuticals?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Omrix Biopharmaceuticals?
The register lists 2 active mandates at Omrix Biopharmaceuticals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Omrix Biopharmaceuticals within its sector?
By total assets for 2025, Omrix Biopharmaceuticals ranks among the 50 largest of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.
The full file of Omrix Biopharmaceuticals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →